Johnson & Johnson publie ses résultats sur une base trimestrielle. Ces rapports trimestriels sur les résultats donnent aux investisseurs un aperçu des résultats financiers d'une entreprise sur une période de 3 mois. Les rapports sur les résultats incluent presque toujours les résultats du BPA et du chiffre d'affaires.
Analysez l'historique des bénéfices de Johnson & Johnson en utilisant des tris et des filtres avancés.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
JNJ | Johnson & Johnson | $2.04 | $2.53 | — | — | $22.52B | $24.12B | — | — | 01/21/2026 | |
JNJ | Johnson & Johnson | $2.42 | $2.76 | $2.80 | 1.45% | $22.47B | $23.75B | $23.99B | 1.03% | 10/14/2025 | |
JNJ | Johnson & Johnson | $2.82 | $2.67 | $2.77 | 3.75% | $22.45B | $22.83B | $23.74B | 3.98% | 07/16/2025 | |
JNJ | Johnson & Johnson | $2.71 | $2.60 | $2.77 | 6.54% | $21.38B | $21.57B | $21.89B | 1.50% | 04/15/2025 | |
JNJ | Johnson & Johnson | $2.29 | $2.02 | $2.04 | 0.99% | $21.39B | $22.45B | $22.52B | 0.31% | 01/22/2025 | |
JNJ | Johnson & Johnson | $2.66 | $2.21 | $2.42 | 9.50% | $21.35B | $22.16B | $22.47B | 1.40% | 10/15/2024 | |
JNJ | Johnson & Johnson | $2.56 | $2.70 | $2.82 | 4.44% | $21.52B | $22.31B | $22.45B | 0.61% | 07/17/2024 | |
JNJ | Johnson & Johnson | $2.41 | $2.64 | $2.71 | 2.65% | $20.89B | $21.41B | $21.38B | -0.13% | 04/16/2024 | |
JNJ | Johnson & Johnson | $2.05 | $2.28 | $2.29 | 0.44% | $23.71B | $20.99B | $21.39B | 1.93% | 01/23/2024 | |
JNJ | Johnson & Johnson | $2.23 | $2.51 | $2.66 | 5.98% | $20.00B | $21.04B | $21.35B | 1.48% | 10/17/2023 | |
JNJ | Johnson & Johnson | $2.59 | $2.62 | $2.80 | 6.87% | $24.02B | $24.63B | $25.53B | 3.65% | 07/20/2023 | |
JNJ | Johnson & Johnson | $2.67 | $2.51 | $2.68 | 6.77% | $23.43B | $23.67B | $24.75B | 4.55% | 04/18/2023 | |
JNJ | Johnson & Johnson | $2.13 | $2.23 | $2.35 | 5.38% | $24.80B | $23.94B | $23.71B | -0.98% | 01/24/2023 | |
JNJ | Johnson & Johnson | $2.60 | $2.52 | $2.55 | 1.19% | $23.34B | $23.47B | $23.79B | 1.37% | 10/18/2022 | |
JNJ | Johnson & Johnson | $2.48 | $2.57 | $2.59 | 0.78% | $23.32B | $23.81B | $24.02B | 0.88% | 07/19/2022 | |
JNJ | Johnson & Johnson | $2.59 | $2.61 | $2.67 | 2.30% | $22.32B | $23.67B | $23.43B | -1.03% | 04/19/2022 | |
JNJ | Johnson & Johnson | $1.86 | $2.12 | $2.13 | 0.47% | $22.48B | $25.29B | $24.80B | -1.92% | 01/25/2022 | |
JNJ | Johnson & Johnson | $2.20 | $2.36 | $2.60 | 10.17% | $21.08B | $23.74B | $23.34B | -1.69% | 10/19/2021 | |
JNJ | Johnson & Johnson | $1.67 | $2.27 | $2.48 | 9.25% | $18.34B | $22.19B | $23.32B | 5.10% | 07/21/2021 | |
JNJ | Johnson & Johnson | $2.30 | $2.34 | $2.59 | 10.68% | $20.69B | $22.01B | $22.32B | 1.41% | 04/20/2021 | |
JNJ | Johnson & Johnson | $1.88 | $1.82 | $1.86 | 2.20% | $20.75B | $21.67B | $22.48B | 3.71% | 01/26/2021 |
| Trimestre Fiscal | Date de Déclaration | BPA Réel | BPA Estimé | Surprendre % |
|---|---|---|---|---|
| Q3 | 2025-10-14 | $2.80 | $2.76 | 1.45 % |
| Q2 | 2025-07-16 | $2.77 | $2.67 | 3.75 % |
| Q1 | 2025-04-15 | $2.77 | $2.60 | 6.54 % |
| Q4 | 2025-01-22 | $2.04 | $2.02 | 0.99 % |
| Trimestre Fiscal | Date de Déclaration | Revenu Réel | Revenu Estimé | Surprendre % |
|---|---|---|---|---|
| Q3 | 2025-10-14 | $23.99B | $23.75B | 1.03 % |
| Q2 | 2025-07-16 | $23.74B | $22.83B | 3.98 % |
| Q1 | 2025-04-15 | $21.89B | $21.57B | 1.50 % |
| Q4 | 2025-01-22 | $22.52B | $22.45B | 0.31 % |
Johnson & Johnson (JNJ) est prévu pour annoncer ses bénéfices le janvier 21, 2026. Les derniers bénéfices rapportés étaient pour Q3 le octobre 14, 2025.
Le BPA réel était de $2.80, ce qui dépassé l'estimation de $2.76.
Le chiffre d'affaires réel était de $24B, ce qui dépassé l'estimation de $23.7B.
Parcourir estimations des bénéfices, EPS et chiffre d'affaires sur toutes les actions.